These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 1697196)
1. Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig. Subissi A; Guelfi M; Criscuoli M Br J Pharmacol; 1990 Jul; 100(3):502-6. PubMed ID: 1697196 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623 [TBL] [Abstract][Full Text] [Related]
3. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation. Takahama K; Araki T; Fuchikami J; Kohjimoto Y; Miyata T J Pharm Pharmacol; 1996 Oct; 48(10):1027-33. PubMed ID: 8953504 [TBL] [Abstract][Full Text] [Related]
4. The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig. Greenberg R; Osman GH; O'Keefe EH; Antonaccio MJ Eur J Pharmacol; 1979 Aug; 57(4):287-94. PubMed ID: 385332 [TBL] [Abstract][Full Text] [Related]
5. Role of tachykinins in enhancement of bradykinin-induced bronchoconstriction by captopril. Arakawa M; Majima M; Nagai K; Goto F; Katori M Inflamm Res; 1996 Feb; 45(2):75-82. PubMed ID: 8907588 [TBL] [Abstract][Full Text] [Related]
6. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Shore SA; Stimler-Gerard NP; Coats SR; Drazen JM Am Rev Respir Dis; 1988 Feb; 137(2):331-6. PubMed ID: 2449104 [TBL] [Abstract][Full Text] [Related]
7. Synergistic potentiation by captopril and propranolol of bradykinin-induced bronchoconstriction in the guinea-pig. Lau WA; Rechtman MP; Boura AL; King RG Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):849-57. PubMed ID: 2692888 [TBL] [Abstract][Full Text] [Related]
8. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo. Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322 [TBL] [Abstract][Full Text] [Related]
9. Influence of several peptidase inhibitors on the pro-inflammatory effects of substance P, capsaicin and collagenase. Damas J; Bourdon V; Liégeois JF; Simmons WH Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):662-9. PubMed ID: 8938667 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of the potentiation of neurally-induced bronchoconstriction by gallamine in the guinea-pig. Del Monte M; Omini C; Subissi A Br J Pharmacol; 1990 Mar; 99(3):582-6. PubMed ID: 2184912 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline. Shirota M; Kajiwara Y; Iijima M; Kitabatake K Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521 [TBL] [Abstract][Full Text] [Related]
12. The potentiation of cardiodepressant and hypotensive effects of bradykinin by enalapril and captopril both in vitro and in vivo. Prostran M; Samardzić R; Todorović Z; Jovanović-Mićić D; Japundzić N; Beleslin BD Gen Pharmacol; 1991; 22(6):995-1000. PubMed ID: 1810815 [TBL] [Abstract][Full Text] [Related]
13. New aspects on inflammatory reactions and cough following inhibiton of angiotensin converting enzyme. Lindgren BR Acta Physiol Scand Suppl; 1988; 573():1-60. PubMed ID: 2466391 [TBL] [Abstract][Full Text] [Related]
14. Difference among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced microvascular leakage in guinea pig airways. Murata T; Matsumoto Y; Kashida T; Kaminuma O; Naito K; Ikezawa K; Tsuzurahara K Jpn J Pharmacol; 1995 Oct; 69(2):111-8. PubMed ID: 8569047 [TBL] [Abstract][Full Text] [Related]
15. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. Sulpizio AC; Pullen MA; Edwards RM; Brooks DP J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin-converting enzyme in human hand veins. Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M; Schiavi P; Vincent M; Schmitt H J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [TBL] [Abstract][Full Text] [Related]
19. Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo. Belvisi MG; Chung KF; Jackson DM; Barnes PJ Br J Pharmacol; 1988 Oct; 95(2):413-8. PubMed ID: 2465805 [TBL] [Abstract][Full Text] [Related]